Lack of Clinical Control in COPD Patients Depending on the Target and the Therapeutic Option

References

• Agusti A, MacNee W. The COPD control panel: towards personalised medicine in COPD. Thorax. 2013;68(7):687–690. doi:10.1136/thoraxjnl-2012-202772
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Soler-Cataluña JJ, Calle M, et al. Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice. Eur Respir J. 2013;41(6):1252–1256. doi:10.1183/09031936.00118912
   PubMed Web of Science ®Google Scholar
• Singh D, Agusti A, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019;53(5):1900164. doi:10.1183/13993003.00164-2019
   PubMed Web of Science ®Google Scholar
• Ur Rehman A, Hassali MAA, Abbas S, et al. Pharmacological and non-pharmacological management of COPD; limitations and future prospects: a review of current literature. J Public Health. 2020;28(4):357–366. doi:10.1007/s10389-019-01021-3
   Google Scholar
• Busch R, Han MK, Bowler RP, et al. Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. BMC Pulm Med. 2016;16(1):28. doi:10.1186/s12890-016-0191-7
   PubMedGoogle Scholar
• Nibber A, Chisholm A, Soler-Cataluña JJ, et al. Validating the concept of COPD control: a real-world cohort study from the United Kingdom. COPD. 2017;14(5):504–512. doi:10.1080/15412555.2017.1350154
   PubMedGoogle Scholar
• Soler-Cataluña JJ, Alcazar-Navarrete B, Miravitlles M, et al. The concept of control in COPD: a new proposal for optimising therapy. Eur Respir J. 2014;44(4):1072–1075. doi:10.1183/09031936.00064414
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Alcazar B, Miravitlles M. The concept of control of COPD in clinical practice. Int J Chron Obst Pulm Dis. 2014;9:1397–1405.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Almagro P, Huerta A, et al. Determinants of disease control in patients with severe COPD. The CLAVE Study. Eur Resp J. 2019;54:2723.
   Google Scholar
• Lopez-Campos JL, Bustamante V, Muñoz X, et al. Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine—a critical view. COPD. 2014;11(5):591–602. doi:10.3109/15412555.2014.898035
   PubMedGoogle Scholar
• Miravitlles M, Sliwinski P, Rhee CK, et al. Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD. Respir Med. 2018;136:8–14. doi:10.1016/j.rmed.2018.01.019
   PubMed Web of Science ®Google Scholar
• Baloira A, Gonzalez-Moro JMR, Sanjuán E, et al. Degree of control of patients with chronic obstructive pulmonary disease in Spain: SINCON study. BMC Pulm Med. 2018;18(1):183. doi:10.1186/s12890-018-0749-7
   PubMedGoogle Scholar
• Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
   PubMed Web of Science ®Google Scholar
• Hagströmer M, Oja P, Sjöström M. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr. 2006;9(6):755–762. doi:10.1079/PHN2005898
   PubMed Web of Science ®Google Scholar
• Plaza V, Fernández-Rodríguez C, Melero C, et al. Validation of the “Test of the Adherence to Inhalers” (TAI) for asthma and COPD patients. J Aerosol Med Pulm Drug Deliv. 2016;29(2):142–152. doi:10.1089/jamp.2015.1212
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383. doi:10.1016/0021-9681(87)90171-8
   PubMedGoogle Scholar
• Molina paris J. How can we define well-controlled chronic obstructive pulmonary disease? Expert Rev Respir Med. 2013;7(sup2):3–15. doi:10.1586/ers.13.15
   PubMed Web of Science ®Google Scholar
• Chatila WM, Thomashow BM, Minai OA, et al. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):549–555. doi:10.1513/pats.200709-148ET
   PubMedGoogle Scholar
• Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. doi:10.1136/thx.2009.113662
   PubMed Web of Science ®Google Scholar
• Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–342. doi:10.1378/chest.10-2521
   PubMed Web of Science ®Google Scholar
• Watz H, Pitta F, Rochester CL, et al. An official European Respiratory Society statement on physical activity in COPD. Eur Respir J. 2014;44(6):1521–1537. doi:10.1183/09031936.00046814
   PubMed Web of Science ®Google Scholar
• Guimarães M, Bugalho A, Oliveira AS, et al. COPD control: can a consensus be found? Rev Port Pneumol. 2016;22(3):167–176. doi:10.1016/j.rppnen.2016.01.004
   PubMedGoogle Scholar
• Hillas G, Perlikos F, Tsiligianni I, et al. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109. doi:10.2147/COPD.S54473
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Baek S, Vithlani V, et al. Optimal bronchodilation for COPD patients: are all long-acting β 2 -agonist/long-acting muscarinic antagonists the same? Tuberc Respir Dis. 2018;81(3):198–215. doi:10.4046/trd.2018.0040
   PubMed Web of Science ®Google Scholar
• Humenberger M, Horner A, Labek A, et al. Adherence to inhaled therapy and its impact on chronic obstructive pulmonary disease (COPD). BMC Pulm Med. 2018;18(1):163. doi:10.1186/s12890-018-0724-3
   PubMed Web of Science ®Google Scholar
• George M. Adherence in asthma and COPD: new strategies for an old problem. Respir Care. 2018;63(6):818–831. doi:10.4187/respcare.05905
   PubMed Web of Science ®Google Scholar
• Bai JW, Chen XX, Liu S, et al. Smoking cessation affects the natural history of COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:3323–3328. doi:10.2147/COPD.S150243
   PubMed Web of Science ®Google Scholar